Related Experiment Video
Updated: May 30, 2026

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
Published on: July 13, 2019
A treatment reengagement intervention for syringe exchangers
Michael Kidorf1, Van L King, Jessica Peirce
1Department of Psychiatry and Behavioral Sciences, Addiction Treatment Services – BBRC, Johns Hopkins University School of Medicine, Bayview Medical Center, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA. mkidorf@jhmi.edu
None:
Poor sustained treatment engagement limits the effectiveness of all modalities of substance abuse treatment. This study evaluated the efficacy of a novel treatment reengagement intervention for a subset of syringe-exchange program (SEP) participants (N = 113) that had enrolled in treatment as part of a 4-month clinical trial (M. Kidorf et al., 2009). Three reengagement conditions for participants leaving treatment were compared. Motivational referral condition (MRC) participants (n = 31) could attend group sessions that focused on renewing treatment interest. MRC plus incentive (MRC + I) participants (n = 49) could receive modest monetary incentives for attending these sessions and reenrolling in treatment. Standard referral condition participants (n = 33) could not attend groups or receive incentives. Across a 1-year observation window, almost all study participants (86%) were discharged from treatment. MRC + I participants attended more group sessions than MRC participants and were considerably more likely to reenroll in treatment than participants in the other study conditions. Reengagement strategies can further enhance the public health benefits of SEPs by increasing rates of treatment participation over time.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Kidney Transplant III: Nursing Management
Continuous Renal Replacement Therapy
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
